[Information] The RNA Technologies in Vaccine and Therapy: From Theory to Practice

In the wake of the impact of COVID-19, RNA technology has made tremendous strides in its application to biotechnology and medical fields. Currently, its development has moved beyond vaccines into clinical drug therapies.

The Taiwan Society for Personalized Medicine has specially invited experts from both academia and industry on the 28th of this month to jointly present the latest developments in RNA, from academic theory to clinical practice.

Regarding mRNA cancer vaccines, two major mRNA COVID vaccine companies have formed strategic alliances with two leading cancer drug companies (BNT/Pfizer and Moderna/MSD).

For this event, we have invited the heads of the medical departments of Pfizer and MSD to share the latest progress in their cancer vaccine development. It promises to be a fascinating discussion!

Sign up now before spaces fill up!

Registration link: https://tinyurl.com/3arb59my

Event Date: Saturday, September 28, 2024, 14:00-17:30

Venue: Lotus Room + Camellia Room, Courtyard by Marriott Taipei (No. 6, Section 3, Minsheng East Road, Taipei 10480)

Registration limit: 60 participants (Free for primary/co-organizing members)

Organizer: Taiwan Society for Personalized Medicine

Co-organizers: Taipei Medical University Precision Health Center, Taipei Medical University Hospital Precision Medicine Research Center

Notes:

1. Registration fee: NT$1,000 / Free for members of the organizing unit
2. Sponsorship/Registration fee bank transfer details: Cooperative Bank (006) Shilin Branch Account No. 1427-765-492162
3. The personal information collected in this registration form will only be used for this event. Contact: Ms. Liang Ya-Ping 0958-563069 / a04224@tmu.edu.tw

The organizer reserves the right to modify, change, interpret, or cancel this event. Any changes will be announced on the website without further notice.